These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30961943)

  • 1. Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease.
    Suzuki A; Kondoh Y; Swigris JJ; Matsuda T; Kimura T; Kataoka K; Ando M; Hashimoto N; Sakamoto K; Hasegawa Y
    Respir Med; 2019 Apr; 150():15-20. PubMed ID: 30961943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease.
    Swigris JJ; Yorke J; Sprunger DB; Swearingen C; Pincus T; du Bois RM; Brown KK; Fischer A
    Respir Med; 2010 Sep; 104(9):1350-5. PubMed ID: 20471238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease.
    Suzuki A; Kondoh Y; Swigris JJ; Ando M; Kimura T; Kataoka K; Yamano Y; Furukawa T; Numata M; Sakamoto K; Hasegawa Y
    Respirology; 2018 Mar; ():. PubMed ID: 29575410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.
    Topcu A; Mursaloglu HH; Yalcinkaya Y; Karakurt S; Yagiz B; Alaca Z; Demir M; Coskun BN; Dalkilic E; Inanc N
    Clin Rheumatol; 2021 Sep; 40(9):3797-3805. PubMed ID: 33811590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease.
    Matsuda T; Kondoh Y; Takei R; Sasano H; Fukihara J; Yamano Y; Yokoyama T; Kataoka K; Watanabe F; Kimura T
    Respir Investig; 2024 Nov; 62(6):1088-1093. PubMed ID: 39332275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
    Nagata K; Tomii K; Otsuka K; Tachikawa R; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K
    Respirology; 2012 Apr; 17(3):506-12. PubMed ID: 22257381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
    Mugii N; Someya F
    Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialectal influence on chronic pulmonary disease assessment test: the reliability and validity study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():541-8. PubMed ID: 25792822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study.
    Ma C; Meng K; Shi S; Zhao T; Chen S; Zhou X; Shu R; Ma M; Tian M; Ding J
    Eur J Med Res; 2023 Sep; 28(1):393. PubMed ID: 37773193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease.
    Bevanda L; Mok V; Lin K; Assayag D; Fisher JH; Johannson KA; Khalil N; Kolb M; Manganas H; Marcoux V; Sadatsafavi M; Wong AW; Ryerson CJ
    Ann Am Thorac Soc; 2024 Jul; 21(7):1007-1014. PubMed ID: 38315632
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.
    Yorke J; Swigris J; Russell AM; Moosavi SH; Ng Man Kwong G; Longshaw M; Jones PW
    Chest; 2011 Jan; 139(1):159-64. PubMed ID: 20595454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects.
    Małysiak-Szpond S; Mozga M; Miądlikowska E; Miłkowska-Dymanowska J; Białas AJ; Piotrowski WJ
    PLoS One; 2022; 17(12):e0278601. PubMed ID: 36574413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.